Fundamental form of a population TCP model in the limit of large heterogeneity

Medical Physics

Volumn 33, Issue 6, 2006, Pages 1634-1642

  Carlone, Marco C ^a   Warkentin, Brad ^a   Stavrev, Pavel ^a   Fallone, B Gino ^a,b  

^a CROSS CANCER INSTITUTE   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

D50; Heterogeneity; Parameter relations; Population; TCP; 50

Indexed keywords

POPULATION STATISTICS;

EXTERNAL BEAM RADIOTHERAPY; HETEROGENEITY; MEAN AND STANDARD DEVIATIONS; PARAMETER RELATIONS; PARAMETERS CHARACTERIZING; POPULATION; RADIOBIOLOGICAL PARAMETERS; TUMOR CONTROL PROBABILITY;

TRANSMISSION CONTROL PROTOCOL;

ARTICLE; CANCER CONTROL; CLONOGENESIS; EXTERNAL BEAM RADIOTHERAPY; POISSON DISTRIBUTION; POPULATION DYNAMICS; POPULATION MODEL; PRIORITY JOURNAL; PROBABILITY; RADIATION RESPONSE; RADIOBIOLOGY; RADIOSENSITIVITY; STATISTICAL PARAMETERS; TUMOR CONTROL PROBABILITY;

EID: 33744795784     PISSN: 00942405     EISSN: None     Source Type: Journal    
DOI: 10.1118/1.2193690     Document Type: Article

References (42)

1. S. L. Tucker and E. L. Travis, " Comments on a time-dependent version of the linear-quadratic model., " Radiother. Oncol. 18 (2), 155-163 (1990).
2. A. Y. Yakovlev, " Comments on the distribution of clonogens in irradiated tumors., " Radiat. Res. 134 (1), 117-120 (1993).
3. W. S. Kendal, " A closed-form description of tumour control with fractionated radiotherapy and repopulation., " Int. J. Radiat. Biol. 73 (2), 207-210 (1998).
4. M. Zaider and G. N. Minerbo, " Tumour control probability: A formulation applicable to any temporal protocol of dose delivery., " Phys. Med. Biol. 45 (2), 279-293 (2000).
5. M. Zaider, M. J. Zelefsky, L. G. Hanin, A. D. Tsodikov, A. Y. Yakovlev, and S. A. Leibel, " A survival model for fractionated radiotherapy with an application to prostate cancer., " Phys. Med. Biol. 46 (10), 2745-2758 (2001).
6. L. G. Hanin, M. Zaider, and A. Y. Yakovlev, " Distribution of the number of clonogens surviving fractionated radiotherapy: A long-standing problem revisited., " Int. J. Radiat. Biol. 77 (2), 205-213 (2001).
7. L. G. Hanin, " A stochastic model of tumor response to fractionated radiation: Limit theorems and rate of convergence., " Math. Biosci. 191 (1), 1-17 (2004).
8. M. Carlone, D. Wilkins, B. Nyiri, and P. Raaphorst, " Comparison of alpha/beta estimates from homogeneous (individual) and heterogeneous (population) tumor control models for early stage prostate cancer., " Med. Phys. 30 (10), 2832-2848 (2003).
9. J. D. Fenwick, " Predicting the radiation control probability of heterogeneous tumour ensembles: Data analysis and parameter estimation using a closed-form expression., " Phys. Med. Biol. 43 (8), 2159-2178 (1998).
10. S. Webb, " Optimum parameters in a model for tumor-control probability including interpatient heterogeneity., " Phys. Med. Biol. 39 (11), 1895-1914 (1994).
11. B. Warkentin, P. Stavrev, N. Stavreva, and B. G. Fallone, " Limitations of a TCP model incorporating population heterogeneity., " Phys. Med. Biol. 50 (15), 3571-3588 (2005).
12. P. Stavrev, B. Warkentin, N. Stavreva, and G. Fallone, " Evaluation of a closed-form tumor control probability solution., " Med. Phys. 29 (6), 1294 (2002).
13. E. L. Travis and S. L. Tucker, " Isoeffect models and fractionated radiation-therapy., " Int. J. Radiat. Oncol., Biol., Phys. 13 (2), 283-287 (1987).
14. H. D. Thames, S. M. Bentzen, I. Turesson, M. Overgaard, and W. Vandenbogaert, " Time-dose factors in radiotherapy-A review of the human data., " Radiother. Oncol. 19 (3), 219-235 (1990).
15. R. J. Yaes, " Linear-quadratic model isoeffect relations for proliferating tumor-cells for treatment with multiple fractions per day., " Int. J. Radiat. Oncol., Biol., Phys. 17 (4), 901-905 (1989).
16. T. E. Wheldon and A. E. Amin, " The linear quadratic model., " Br. J. Radiol. 61 (728), 700-702 (1988).
17. H. R. Withers, J. M. G. Taylor, and B. Maciejewski, " The hazard of accelerated tumor clonogen repopulation during radiotherapy., " Acta Oncol. 27 (2), 131-146 (1988).
18. J. Van Dyk, K. Mah, and T. J. Keane, " Radiation-induced lung damage-dose-time-fractionation considerations., " Radiother. Oncol. 14 (1), 55-69 (1989).
19. J. Vandegeijn, " Incorporating the time factor into the linear-quadratic model., " Br. J. Radiol. 62 (735), 296-298 (1989).
20. J. M. G. Taylor, H. R. Withers, and W. M. Mendenhall, " Dose-time considerations of head and neck squamous-cell carcinomas treated with irradiation., " Radiother. Oncol. 17 (2), 95-102 (1990).
21. B. Maciejewski, H. R. Withers, J. M. G. Taylor, and A. Hliniak, " Dose fractionation and regeneration in radiotherapy for cancer of the oral cavity and oropharynx-tumor dose-response and repopulation., " Int. J. Radiat. Oncol., Biol., Phys. 16 (3), 831-843 (1989).
22. B. Maciejewski, H. R. Withers, J. M. G. Taylor, and A. Hliniak, " Dose fractionation and regeneration in radiotherapy for cancer of the oral cavity and oropharynx. 2. Normal tissue responses-acute and late effects., " Int. J. Radiat. Oncol., Biol., Phys. 18 (1), 101-111 (1990).
23. J. F. Fowler, " The linear-quadratic formula and progress in fractionated radiotherapy., " Br. J. Radiol. 62 (740), 679-694 (1989).
24. R. G. Dale, " Radiobiological assessment of permanent implants using tumor repopulation factors in the linear-quadratic model., " Br. J. Radiol. 62 (735), 241-244 (1989).
25. R. G. Dale, " Time-dependent tumor repopulation factors in linear-quadratic equations-Implications for treatment strategies., " Radiother. Oncol. 15 (4), 371-382 (1989).
26. S. A. Roberts and J. H. Hendry, " The delay before onset of accelerated tumour cell repopulation during radiotherapy: A direct maximum-likelihood analysis of a collection of worldwide tumour-control data., " Radiother. Oncol. 29 (1), 69-74 (1993).
27. S. A. Roberts and J. H. Hendry, " A realistic closed-form radiobiological model of clinical tumor-control data incorporating intertumor heterogeneity., " Int. J. Radiat. Oncol., Biol., Phys. 41 (3), 689-699 (1998).
28. M. Goitein, A. Niemierko, and P. Okunieff, " The probability of controlling an inhomogeneously irradiated tumour: A strategem for improving tumour control through partial tumour boosting., " presented at the 19th L. H. Gray Conference: Quantitative Imaging in Oncology, Newcastle,, UK, 1995 (unpublished).
29. D. J. Brenner and E. J. Hall, " In response to Drs. King and Mayo: Low alpha/beta values for prostate appear to be independent of modeling details., " Int. J. Radiat. Oncol., Biol., Phys. 47 (2), 538-539 (2000).
30. J. D. Chapman, " Single-hit mechanism of tumour cell killing by radiation., " Int. J. Radiat. Biol. 79 (2), 71-81 (2003).
31. A. Jackson, R. K. Ten Haken, J. M. Robertson, M. L. Kessler, G. J. Kutcher, and T. S. Lawrence, " Analysis of clinical complication data for radiation hepatitis using a parallel architecture model., " Int. J. Radiat. Oncol., Biol., Phys. 31 (4), 883-891 (1995).
32. P. Stavrev, N. Stavreva, A. Niemierko, and M. Goitein, " Generalization of a model of tissue response to radiation based on the idea of functional subunits and binomial statistics., " Phys. Med. Biol. 46 (5), 1501-1518 (2001).
33. M. Carlone, D. Wilkins, B. Nyiri, and P. Raaphorst, " TCP isoeffect analysis using a heterogeneous distribution of radiosensitivity., " Med. Phys. 31 (5), 1176-1182 (2004).
34. S. M. Bentzen and S. L. Tucker, " Quantifying the position and steepness of radiation dose-response curves., " Int. J. Radiat. Biol. 71 (5), 531-542 (1997).
35. F. M. Buffa, S. E. Davidson, R. D. Hunter, A. E. Nahum, and C. M. L. West, " Incorporating biologic measurements (SF2, CFE) into a tumor control probability model increases their prognostic significance: A study in cervical carcinoma treated with radiation therapy., " Int. J. Radiat. Oncol., Biol., Phys. 50 (5), 1113-1122 (2001).
36. D. J. Brenner and E. J. Hall, " Fractionation and protraction for radiotherapy of prostate carcinoma., " Int. J. Radiat. Oncol., Biol., Phys. 43 (5), 1095-1101 (1999).
37. J. Fowler, R. Chappell, and M. Ritter, " Is alpha/beta for prostate tumors really low?, " Int. J. Radiat. Oncol., Biol., Phys. 50 (4), 1021-1031 (2001).
38. H. B. Kal and M. P. R. Van Gellekom, " How low is the alpha/beta ratio for prostate cancer?, " Int. J. Radiat. Oncol., Biol., Phys. 57 (4), 1116-1121 (2003).
39. J. Z. Wang, M. Guerrero, and X. A. Li, " How low is the alpha/beta ratio for prostate cancer?, " Int. J. Radiat. Oncol., Biol., Phys. 55 (1), 194-203 (2003).
40. M. Guerrero and X. A. Li, " Analysis of a large number of clinical studies for breast cancer radiotherapy: Estimation of radiobiological parameters for treatment planning., " Phys. Med. Biol. 48 (20), 3307-3326 (2003).
41. W. D. D'Souza, H. D. Thames, and D. A. Kuban, " Dose-volume conundrum for response of prostate cancer to brachytherapy: Summary dosimetric measures and their relationship to tumor control probability., " Int. J. Radiat. Oncol., Biol., Phys. 58 (5), 1540-1548 (2004).
42. F. M. Buffa, J. D. Fenwick, and A. E. Nahum, " Concerning Roberts and Hendry IJROBP 1998;41: 689-699., " Int. J. Radiat. Oncol., Biol., Phys. 44 (3), 737-739 (1999).